Advertisement
Organisation › Details
Sumitomo Dainippon Pharma Co. Ldt.
Start | 2005-10-01 merged | |
Group | Sumitomo (Group) | |
Industry | pharmaceutical | |
Street | 6-8 Doshomachi Chuo-ku | |
City | 541-0045 Osaka | |
Tel | +81-6-6203-5321 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | G: 5,001 to 10,000 (2006-03-31) |
Record changed: 2023-07-10 |
Advertisement
More documents for Sumitomo (Group)
- [1] Urovant Sciences. (7/5/22). "Press Release: Urovant Sciences and Pierre Fabre Médicament Enter into Exclusive License Agreement to Commercialize Vibegron for the Treatment of Overactive Bladder in the European Economic Area, UK, and Switzerland". Basel &...
- [2] Exscientia Ltd.. (5/13/21). "Press Release: Exscientia Announces Second Molecule Created Using AI from Sumitomo Dainippon Pharma Collaboration to Enter Phase 1 Clinical Trial"....
- [3] Gain Therapeutics, Inc.. (9/10/20). "Press Release: Gain Therapeutics Announces Research Collaboration with Sumitomo Dainippon Pharma Co., Ltd to Advance Gain’s Lysosomal Enzyme Allosteric Regulator Program". Bethesda, MD....
- [4] CureVac AG. (2/26/20). "Press Release: CureVac Appoints Alan Kimura, MD, PhD as Head of the Newly Created Department “Rare Diseases”". Tübingen & Boston, MA....
- [5] Exscientia Ltd.. (1/30/20). "Press Release: Sumitomo Dainippon Pharma and Exscientia Joint Development New Drug Candidate Created Using Artificial Intelligence (AI) Begins Clinical Trial"....
- [6] Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel....
- [7] Rentschler Biopharma SE. (10/4/19). "Press Release: Rentschler Biopharma Announces Enhanced Collaboration with Summit Pharmaceuticals International Corporation to Expand Japanese Operation-Base". Laupheim & Milford, MA....
- [8] Exscientia Ltd.. (3/22/19). "Press Release: Exscientia Continues Expansion with Establishment of a Subsidiary in Japan to Target the Pharmaceutical Market Across Asia". Oxford & Osaka....
- [9] ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin....
- [10] Roivant Sciences GmbH. (8/28/18). "Press Release: Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder". Basel & Irvine, CA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top